BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2830912)

  • 1. [cGMP-dependent cyclic nucleotide phosphodiesterase from human lymphoid cells].
    Azhaeva EV; Severin SE; Kondrat'ev AD
    Biokhimiia; 1987 Nov; 52(11):1781-5. PubMed ID: 2830912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Kinetic properties and regulation of cyclic nucleotide phosphodiesterases in lymphoid cells].
    Azhaeva EV; Severin ES
    Bioorg Khim; 1987 Sep; 13(9):1157-63. PubMed ID: 2827690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggregation states of cyclic nucleotide phosphodiesterase of murine thymocytes.
    Sobolev AS; Rybalkin SD
    Cell Biochem Funct; 1986 Jul; 4(3):205-11. PubMed ID: 3015450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equilibrium kinetics model for the cGMP-stimulated phosphodiesterase of brain coated vesicles.
    Silva WI; Puszkin S
    Bol Asoc Med P R; 1990 Sep; 82(9):407-11. PubMed ID: 1963777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The binding of cyclic nucleotide analogs to a purified cyclic GMP-stimulated phosphodiesterase from bovine adrenal tissue.
    Erneux C; Miot F; Van Haastert PJ; Jastorff B
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(5):463-72. PubMed ID: 2999203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multiple forms of cyclic nucleotide phosphotransferases in mouse thymocytes].
    Rybalkin SD; Kurennaia GS; Sobolev AS
    Biokhimiia; 1984 Dec; 49(12):1927-33. PubMed ID: 6098315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The process of cyclic adenosine-3',5'-monophosphate phosphodiesterase activation by 2',5'-oligoadenylate].
    Tunitskaia VL; Itkes AV; Kochetkova MN; Severin ES
    Biokhimiia; 1983 Oct; 48(10):1721-5. PubMed ID: 6315087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [cGMP-activated phosphodiesterase from human brain: kinetic and regulatory properties].
    Bobruskin ID; Medvedeva MV; Severin ES
    Biokhimiia; 1991 Jun; 56(6):999-1010. PubMed ID: 1657216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methylation of 3',5'-cGMP phosphodiesterase in retinal photoreceptor membranes].
    Artem'ev NO; Etingof RN
    Biokhimiia; 1987 Jan; 52(1):154-9. PubMed ID: 3028508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cyclic AMP-specific nucleotide phosphodiesterase from the insoluble fraction of the human brain].
    Kireeva NN; Bobruskin ID; Severin SE
    Biokhimiia; 1995 May; 60(5):694-708. PubMed ID: 7662796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of guanosine 3',5'-monophosphate-phosphodiesterase activity by adrenocorticotropic hormone-activated increase of guanosine 3',5'-monophosphate in isolated adrenocortical carcinoma cells.
    Perchellet JP; Sharma RK
    Endocrinology; 1979 Oct; 105(4):879-83. PubMed ID: 225158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and regulation of the cGMP-binding, cGMP-specific phosphodiesterase (PDE5) in human colonic epithelial cells: role in the induction of cellular refractoriness to the heat-stable enterotoxin peptide.
    Bakre MM; Sopory S; Visweswariah SS
    J Cell Biochem; 2000 Feb; 77(1):159-67. PubMed ID: 10679826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ca2+-dependent regulation of cGMP-stimulated phosphodiesterase from the soluble fraction of the human brain].
    Medvedeva MV; Bobruskin ID
    Biokhimiia; 1994 Jun; 59(6):866-72. PubMed ID: 8075251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ca2+ induces an increase in cGMP-phosphodiesterase activity in squid retinal photoreceptors.
    Brown JE; Kelman ES
    Biochem Biophys Res Commun; 1996 Jul; 224(3):684-9. PubMed ID: 8713107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in cyclic AMP phosphodiesterase activities during differentiation of 3T3-L1 cells.
    Manganiello VC; Reed BC; Lieberman FS; Moss J; Lane MD; Vaughan M
    J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(2):143-54. PubMed ID: 6196386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic nucleotide derivatives as probes of phosphodiesterase catalytic and regulatory sites.
    Erneux C; Couchie D; Dumont JE; Jastorff B
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():107-18. PubMed ID: 6326517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental control of cAMP-induced Ca2+-influx by cGMP: influx is delayed and reduced in a cGMP-phosphodiesterase D deficient mutant of Dictyostelium discoideum.
    Lusche DF; Malchow D
    Cell Calcium; 2005 Jan; 37(1):57-67. PubMed ID: 15541464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of cDNAs for phosphodiesterases that hydrolyze guanosine 3';5'-monophosphate in Escherichia coli.
    Van Lookeren Campagne MM; Villalba-Díaz F; Meacci E; Manganiello VC; Kessin RH
    Second Messengers Phosphoproteins; 1992-1993; 14(3):127-37. PubMed ID: 1345338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modern representations of multiple forms of cyclic nucleotide phosphodiesterases in mammalian tissues].
    Medvedeva MV
    Biokhimiia; 1995 Mar; 60(3):364-86. PubMed ID: 7734612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.